161 related articles for article (PubMed ID: 17714418)
1. The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations.
Valentin N; Gagne K; Kerdudou N; Hallé L; Kaplan C; Killie MK; Skogen B; Muller JY; Bignon JD
Transfusion; 2007 Dec; 47(12):2322-9. PubMed ID: 17714418
[TBL] [Abstract][Full Text] [Related]
2. HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
Wienzek-Lischka S; König IR; Papenkort EM; Hackstein H; Santoso S; Sachs UJ; Bein G
Transfusion; 2017 Mar; 57(3):533-540. PubMed ID: 28019029
[TBL] [Abstract][Full Text] [Related]
3. Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.
Kjeldsen-Kragh J; Ahlen MT
Transfus Apher Sci; 2020 Feb; 59(1):102707. PubMed ID: 31919011
[TBL] [Abstract][Full Text] [Related]
4. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening.
Williamson LM; Hackett G; Rennie J; Palmer CR; Maciver C; Hadfield R; Hughes D; Jobson S; Ouwehand WH
Blood; 1998 Oct; 92(7):2280-7. PubMed ID: 9746765
[TBL] [Abstract][Full Text] [Related]
5. Fetomaternal alloimmune thrombocytopenia.
Ahya R; Turner ML; Urbaniak SJ;
Transfus Apher Sci; 2001 Oct; 25(2):139-45. PubMed ID: 11761276
[TBL] [Abstract][Full Text] [Related]
6. Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201.
L'Abbé D; Tremblay L; Filion M; Busque L; Goldman M; Décary F; Chartrand P
Hum Immunol; 1992 Jun; 34(2):107-14. PubMed ID: 1358865
[TBL] [Abstract][Full Text] [Related]
7. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.
Ahlen MT; Heide G; Husebekk A; Skogen B; Kjeldsen-Kragh J; Stuge TB
Scand J Immunol; 2020 Jul; 92(1):e12890. PubMed ID: 32299122
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.
Kjeldsen-Kragh J; Titze TL; Lie BA; Vaage JT; Kjær M
Blood Adv; 2019 Apr; 3(7):945-951. PubMed ID: 30923048
[TBL] [Abstract][Full Text] [Related]
10. Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome.
Kjeldsen-Kragh J; Fergusson DA; Kjaer M; Lieberman L; Greinacher A; Murphy MF; Bussel J; Bakchoul T; Corke S; Bertrand G; Oepkes D; Baker JM; Hume H; Massey E; Kaplan C; Arnold DM; Baidya S; Ryan G; Savoia HF; Landry D; Shehata N
Blood Adv; 2020 Jul; 4(14):3368-3377. PubMed ID: 32717028
[TBL] [Abstract][Full Text] [Related]
11. Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.
Kjær M; Tiller H; Heide G; Kjeldsen-Kragh J; Skogen B; Husebekk A
PLoS One; 2017; 12(8):e0182957. PubMed ID: 28837581
[TBL] [Abstract][Full Text] [Related]
12. Maternal DRB1*1501, DQA1*0102, DQB1*0602 haplotype in fetomaternal alloimmunization against human platelet alloantigen HPA-6b (GPIIIa-Gln489).
Westman P; Hashemi-Tavoularis S; Blanchette V; Kekomäki S; Laes M; Porcelijn L; Kekomäki R
Tissue Antigens; 1997 Aug; 50(2):113-8. PubMed ID: 9271820
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women.
Sukati H; Bessos H; Barker RN; Urbaniak SJ
Transfusion; 2005 Jul; 45(7):1165-77. PubMed ID: 15987363
[TBL] [Abstract][Full Text] [Related]
14. Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.
Sainio S; Javela K; Tuimala J; Haimila K
Br J Haematol; 2017 Jan; 176(1):111-117. PubMed ID: 27748520
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn.
Killie MK; Husebekk A; Kjeldsen-Kragh J; Skogen B
Haematologica; 2008 Jun; 93(6):870-7. PubMed ID: 18443267
[TBL] [Abstract][Full Text] [Related]
16. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia.
Ghevaert C; Campbell K; Stafford P; Metcalfe P; Casbard A; Smith GA; Allen D; Ranasinghe E; Williamson LM; Ouwehand WH
Transfusion; 2007 Jul; 47(7):1296-305. PubMed ID: 17581167
[TBL] [Abstract][Full Text] [Related]
17. Alloimmune neonatal neutropenia and thrombocytopenia associated with maternal anti HNA-1a, HPA-3b and HLA antibodies.
Marín L; Torío A; Muro M; Fernandez-Parra R; Minguela A; Bosch V; Alvarez-López MR; García-Alonso AM
Pediatr Allergy Immunol; 2005 May; 16(3):279-82. PubMed ID: 15853961
[TBL] [Abstract][Full Text] [Related]
18. Genetic susceptibility and anti-human platelet antigen 5b alloimmunization role of HLA class II and TAP genes.
Semana G; Zazoun T; Alizadeh M; Morel-Kopp MC; Genetet B; Kaplan C
Hum Immunol; 1996 Apr; 46(2):114-9. PubMed ID: 8727210
[TBL] [Abstract][Full Text] [Related]
19. Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.
Loewenthal R; Rosenberg N; Kalt R; Dardik R; Landau M; Yahalom V; Avishai O; Frenkel O; Gazit E; Steinberg DM; Lipitz S; Salomon O
Transfusion; 2013 Feb; 53(2):344-52. PubMed ID: 22671039
[TBL] [Abstract][Full Text] [Related]
20. Expression of a single-chain human leukocyte antigen-DRA/DRB3*01:01 molecule and differential binding of a monoclonal antibody in the presence of specifically bound human platelet antigen-1a peptide.
Bouwmans EE; Smethurst PA; Garner SF; Ouwehand WH; Morley SL
Transfusion; 2014 Jun; 54(6):1478-85. PubMed ID: 24308361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
